跳到正文
Pharmaceutical Commerce·· 4 小时前AI 评分31

Cold Chain Technologies 的 Vijay Paliwal 谈运输路线与时长如何影响冷链包装选择

How Lanes and Duration Shape Cold Chain Packaging Selection

AI 导读

Cold Chain Technologies 高级解决方案与客户体验副总裁 Vijay Paliwal 在 LogiPharma USA 2026 上表示,选择可重复使用被动式、一次性或主动式冷链包装,应先界定运输需管理的风险而非容器本身。

正文

At LogiPharma USA 2026, Cold Chain Technologies' Vijay Paliwal explains how manufacturers should choose between reusable, single-use and active packaging.

Choosing between reusable passive, single-use and active cold chain packaging starts with defining the risk a shipment needs to manage rather than the container itself, according to Vijay Paliwal, vice president of advanced solutions and customer experience at Cold Chain Technologies.

"It's really about what risk you're trying to manage, not so much about what packaging," Paliwal says. Speaking with Pharmaceutical Commerce at LogiPharma USA 2026, where he joined the panel "Reinventing Cold Chain Packaging & Technology: Smarter Systems for a More Predictable and Sustainable Future," Paliwal notes that manufacturers' core competency lies in developing and commercializing drugs, not cold chain transportation, which is why many rely on packaging partners to guide those decisions.

Reusable passive systems tend to fit well-established lanes where manufacturers have solid stability data on the product and end users already accustomed to handling returnable shippers. Sustainability commitments can also tip the decision toward reusable models.

Geography can quickly change the math. Paliwal pointed to shipments to Saudi Arabia, where bringing a shipper back to the U.S. would be "economically unfeasible." Routing it to a regional center in the Middle East is an option, though not always a cost effective one. Home delivery presents a similar calculation. Curbside-recyclable single-use shippers with cellulose-based insulation let patients dispose of packaging at home, avoiding the reverse logistics costs a reusable program carries.

Furthermore, Paliwal notes that active systems come into play when transit durations significantly exceed what passive shippers can support.

Industry data suggests total cost of ownership (TCO) has long been central to these choices. In Peli BioThermal's 2019 Biopharma Cold Chain Logistics Survey, 70% of respondents rated TCO as important or very important, and 79% said reusable containers, though more expensive than single-use containers, were worth the investment.1

Reference

1. Forcinio H. Packaging Preserves the Cold Chain. BioPharm International. April 1, 2020. https://www.biopharminternational.com/view/packaging-preserves-cold-chain-1

Related to this article

来源:Pharmaceutical Commerce · pharmaceuticalcommerce.com